Cognitive performance in depressed patients after chronic use of antidepressants

  title={Cognitive performance in depressed patients after chronic use of antidepressants},
  author={Clarice Gorenstein and Stefania Caldeira de Carvalho and Rinaldo Artes and Ricardo Alberto Moreno and Tania Marcourakis},
RationaleDepressive disorders are conditions that often require continuous treatment, and it is therefore important to evaluate the consequences of prolonged administration. There are few studies assessing cognitive functions of depressed patients after long-term use of antidepressants.ObjectivesThis study evaluated the cognitive performance of depressed patients treated with antidepressants for at least 6 months.MethodsPatients with major depression (DSM-IV) using imipramine for 2.4±0.6 years… 
Serum level of venlafaxine is associated with better memory in psychotic disorders
Working Memory in Patients with Major Depressive Disorder
A deficit of verbal WM correlated with the functional outcome after treatment in patients with major depressive disorder, suggesting that antidepressant therapy with paroxetine might contribute to improvement of verbal working memory.
A Review of Modern Antidepressants' Effects on Neurocognitive Function
The present paper reviews the current literature on modern antidepressants effects on neurocognitive function. Today, it seems justified to state that SSRIs in general do not affect cognitive
Influence of Pharmacotherapy on Cognitive Functions in Depression: A Review of the Literature
This article presents a review of the studies relating to assessment of the effects of various antidepressants on cognitive abilities among patients with depression.
Antidepressant Medications And Cognitive Functioning In Major Depressive Disorder
ANTIDEPRESSANT MEDICATIONS AND COGNITIVE FUNCTIONING IN MAJOR DEPRESSIVE DISORDER by Rachel E. Kay August 2013 Advisor: Dr. Lisa J. Rapport Major: Psychology (Clinical) Degree: Master of Arts
Residual cognitive impairments in remitted depressed patients
The findings indicate that remitted depressed patients who use antidepressant medication still show an increased recognition of facial expression of fear compared to healthy controls, and most of the cognitive impairments associated with depression resolve with recovery through medication, even when recovery is incomplete.
Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine
In contrast to the persistent harmful effects of imipramine, chronic treatment with paroxetine does not alter spatial working memory performance and appears to improve temporal order memory performance.


Memory performance in panic disorder patients after chronic use of clomipramine
Investigation of chronic use of therapeutic doses of clomipramine by outpatients with panic disorder/agoraphobia who were currently in remission showed that low doses of CMI chronically administered to panic patients are associated with diminished metamemory and impaired priming and working memory.
Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients.
The 2 antidepressants proved to be suitable for the long-term treatment of depression in the elderly and to be devoid of detrimental effects on the tested cognitive functions.
Effects of Antidepressants on Cognitive Functioning of Elderly Patients
Data regarding the effects of selective serotonin (5-hydroxytryptamine) reuptake inhibitors on cognitive performance in the elderly indicate no detrimental effect.
Impairment of performance associated with long-term use of benzodiazepines
Performance of chronic users of BDZ was consistently worse than those of the control groups, suggesting an impairment in these patients on both psychomotor and cognitive functions, which were independent of diagnosis and levels of anxiety and depression.
Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects
Both treatments produced improvements in all measures of cognitive and behavioural function, but paroxetine was significantly superior to fluoxetines from Week 3, indicating a possible early effect.
Effects of antidepressants on cognitive functions: A review
Critical flicker fusion threshold and anticholinergic effects of chronic antidepressant treatment in remitted depressives
The persistence of deficits in cognitive performance in major depressive patients taking maintenance antidepressant medication was assessed by examining groups of patients in clinical remission,
Clomipramine, a better reference drug for panic/agoraphobia. II. Psychomotor and cognitive effects
Clomipramine is better than imipramines or alprazolam as a reference drug for panic/agoraphobia and the absence of deleterious effects on cognitive measures known to be affected by benzodiazepines is concluded.
Antidepressants and memory: A review
Antidepressant medications have been in general use since the late 1950s. Many patients are treated as outpatients and often continue with their normal routines during treatment. Individuals may
Cognitive Dysfunction and Imipramine in Outpatient Depressives
The data support the presence of cognitive dysfunction in depression, even in ambulatory patients without substantial impairments of attention or motor functioning and indicate that antidepressant drugs can produce improvement in cognitive function, possibly as a forerunner of clinical improvement.